pneumocystis pneumonia

GPTKB entity

Statements (48)
Predicate Object
gptkbp:instance_of gptkb:healthcare_organization
gptkbp:bfsLayer 4
gptkbp:bfsParent gptkb:trimethoprim-sulfamethoxazole
gptkb:HIV/_AIDS
gptkbp:associated_with gptkb:HIV/_AIDS
gptkbp:caused_by gptkb:Pneumocystis_jirovecii
gptkbp:complications respiratory failure
secondary infections
pulmonary hypertension
gptkbp:first_described_by 1970s
gptkbp:healthcare associated with HIV epidemic
important in transplant medicine
requires awareness in healthcare settings
https://www.w3.org/2000/01/rdf-schema#label pneumocystis pneumonia
gptkbp:is_a_route_for affects alveoli
causes inflammation
characterized by foamy exudate
leads to impaired gas exchange
gptkbp:is_often_used_in immunocompromised individuals
gptkbp:is_protected_by prophylactic antibiotics
gptkbp:research_focus epidemiological studies
vaccine development
treatment optimization
understanding pathogenesis
improved diagnostic methods
gptkbp:risk_factor malnutrition
organ transplantation
chemotherapy
corticosteroid use
gptkbp:social_responsibility CT scan
chest X-ray
more common in developing countries
early treatment improves outcomes
incidence increases with age
bronchoalveolar lavage
depends on immune status
risk of recurrence after treatment
sputum analysis
associated with high mortality rates in untreated cases
gptkbp:symptoms cough
fever
shortness of breath
gptkbp:treatment gptkb:pentamidine
gptkb:trimethoprim-sulfamethoxazole
corticosteroids
can be fatal if untreated
improved with treatment
antimicrobial therapy